1-Methyl-D-tryptophan: Potent IDO Inhibitor for Cancer and Immune Response Research

Explore the critical role of 1-Methyl-D-tryptophan in modulating immune responses and its potential in cancer immunotherapy.

Get a Quote & Sample

Key Product Advantages

Potent IDO Inhibition

1-Methyl-D-tryptophan provides robust inhibition of IDO and IDO2, essential for unlocking immune responses by preventing tryptophan depletion in the tumor microenvironment.

Enhanced Immune Cell Activity

Utilize 1-Methyl-D-tryptophan to boost the effectiveness of CD8+ T-cells, critical for mounting a strong antitumor and antiviral defense.

Preclinical Efficacy

Demonstrated ability to reduce tumor volume in xenograft models highlights the in vivo potential of 1-Methyl-D-tryptophan in cancer treatment strategies.

Key Applications

Cancer Immunotherapy

As an IDO inhibitor, 1-Methyl-D-tryptophan is instrumental in developing next-generation cancer immunotherapies aimed at overcoming immune suppression.

Antiviral Research

Its role in enhancing CD8+ T-cell responses makes 1-Methyl-D-tryptophan a key compound for research into novel antiviral treatments.

Inflammatory Disease Study

Investigating the kynurenine pathway with 1-Methyl-D-tryptophan can shed light on chronic inflammatory conditions and potential therapeutic interventions.

Immune Modulation Research

The compound serves as a vital tool for scientists studying broader immune system regulation and response mechanisms.